Stocks and Investing
Stocks and Investing
Thu, January 5, 2023
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
[ Thu, Jan 05th 2023
] - WOPRAI
Julian Mitchell Maintained (ALLE) at Buy with Increased Target to $129 on, Jan 5th, 2023
Julian Mitchell of Barclays, Maintained "Allegion plc" (ALLE) at Buy with Increased Target from $127 to $129 on, Jan 5th, 2023.
Julian has made no other calls on ALLE in the last 4 months.
There are 5 other peers that have a rating on ALLE. Out of the 5 peers that are also analyzing ALLE, 2 agree with Julian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John Walsh of "Credit Suisse" Maintained at Hold with Increased Target to $116 on, Friday, October 28th, 2022
- Joshua Pokrzywinski of "Morgan Stanley" Maintained at Hold with Increased Target to $107 on, Friday, October 28th, 2022
These are the ratings of the 3 analyists that currently disagree with Julian
- Jeffrey Sprague of "Vertical Research" Upgraded from Hold to Strong Buy and Held Target at $128 on, Tuesday, January 3rd, 2023
- Joseph O'Dea of "Wells Fargo" Maintained at Buy with Increased Target to $116 on, Friday, October 28th, 2022
- Brett Linzey of "Mizuho" Maintained at Strong Buy with Decreased Target to $114 on, Wednesday, September 21st, 2022
Contributing Sources